Key result
Fenofibrate reduces mitochondrial damage in diabetic cardiomyopathy models by promoting EHHADH expression.
Why the study?
The role of mitochondria-related gene EHHADH in diabetic cardiomyopathy and its potential protective effects were not well understood.
EHHADH exerts a protective effect in diabetic cardiomyopathy by reducing mitochondrial damage, oxidative stress, and cardiomyocyte apoptosis, which can be promoted by fenofibrate.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for EHHADH-targeted therapy in diabetic cardiomyopathy; clinical trials needed before any practice implications.
Diabetic cardiomyopathy (DCM) induces myocardial lipotoxicity, mitochondria are essential for lipid metabolism. This study explored the role of mitochondria-related gene Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase (EHHADH) in DCM. Mitochondria-related differentially expressed genes(Mito DEGs) were screened from DCM and mitochondrial datasets. Protein-protein interaction (PPI) network and CytoHubba were applied to identify hub Mito DEGs. Hub gene expression in vivo and vitro DCM models was verified by western blot and RT-qPCR. H9C2 cell apoptosis was detected by Tunel and flow cytometry, lipid accumulation was clarified by oil red O staining, oxidative stress was assessed by detecting ROS, BODIPY-C11 and malondialdehyde(MDA). Mitochondrial function was determined by JC-1 staining and ATP levels. After adding Fenofibrate(FNB), apoptosis proteins were detected by western blot. DCM genes are enriched in fatty acid metabolism pathway. EHHADH is the most critical hub gene in all hub Mito DEGs and upregulated in vivo and vitro DCM models. EHHADH knockdown aggravate high glucose and palmitic acid (HGHP)-treated H9C2 cell apoptosis, oxidative stress, lipid peroxidation, and lipid accumulation, which are associated with mitochondrial functional damage. FNB promoted EHHADH expression, thereby reducing apoptosis, lipid accumulation, and mitochondrial damage in myocardial cells. EHHADH exerts a protective effect in DCM by reducing mitochondrial damage, oxidative stress, lipid accumulation, and cardiomyocyte apoptosis.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied Diabetic cardiomyopathy. EHHADH knockdown and Fenofibrate was evaluated on Mitochondrial damage, oxidative stress, lipid accumulation, and cardiomyocyte apoptosis. EHHADH knockdown aggravated apoptosis and lipid accumulation in diabetic cardiomyopathy models, while Fenofibrate promoted EHHADH expression and reduced mitochondrial damage.
Synapse has enriched 10 related papers. Consider them for comparative context: